Related Articles
Prognostic factors for survival after enucleation for choroidal melanoma.
Comparison of standard-dose and half‑dose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysis
PROGNOSTIC-SIGNIFICANCE OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN ADENOCARCINOMA OF THE LUNG
PCNA EXPRESSION AND AG-NOR SCORE IN BREAST-CANCER - CORRELATION WITH CLINICOPATHOLOGICAL VARIABLES AND PATIENT SURVIVAL
Tumor proliferative compartment in non-Hodgkin's lymphoma